IE000JKS50V3
IE000JKS50V3
Amundi S&P World Health Care Screened UCITS ETF Dist
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
27.69
Weighted Fwd P/E
17.41
Avg P/FCF
25.68
Avg FCF Yield
3.84%
Avg EV / EBITDA
17.17
Avg EV / Revenue
6.19
Avg Price-to-Book (P/B)
49.34
Avg Price-to-Sales (P/S)
5.82
Avg Dividend Yield
0.01%
P/E Compression (Trailing vs Fwd)
-37.13%
Avg Debt-to-Equity (D/E)
201.07%
<50% (11.87%) 50-150% (49.88%) >150% (24.71%) Unreported (13.54%)
Profitability Analysis
84 Holdings CountProfitable 99.19%
Profitable 99.19%
81
Holdings Count (96.43%)
Unprofitable 0.81%
3
Holdings Count (3.57%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
34.6%
Top 10
52.6%
Top 25
79.9%
50% Threshold
Top 10
The top 10 positions account for 52.6% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
16 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (17.7%+)
High (46.0%+)
Top (63.6%+)
Country Breakdown
Max: 70.71%70.71%
10.57%
5.29%
2.68%
2.61%
2.03%
1.51%
0.89%
0.76%
0.56%
0.35%
0.30%
0.23%
0.15%
0.09%
0.08%
Sector Distribution
2 SectorHealthcare
98.79%
Unknown
0.15%
Industry Distribution
9 IndustriesDrug Manufacturers - General
54.86%
Medical Devices
10.17%
Healthcare Plans
9.06%
Diagnostics & Research
7.61%
Biotechnology
6.79%
Medical Instruments & Supplies
5.10%
Medical Distribution
3.28%
Other
2.07%
Market Cap Distribution
84 Holdings CountMega Cap (> 200B)
(10) 49.63%
Large Cap (10B - 200B)
(63) 48.55%
Mid Cap (2B - 10B)
(10) 0.62%
Unclassified
(1) 0.15%